Search results for: 'distributed diseas of service da1a'

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

Fiber optic sensing solutions utilize the light medium as the physical source to detect variations in temperature, acoustics, strain, and vibrational parameters. Fiber optic sensing uses an optical fiber cable as the sensor device to create a continuous point of sensing along the fiber cable. This method of sensing is known as distributed fiber opt...

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...

06 Sep 2016  |  Asia Pacific  |  Market Research

Asia-Pacific Distributed Denial of Service (DDoS) Solutions Market

Rise of Volumetric, Sophisticated, and Ransom DDoS Attacks Toward Organizations Driving the Market

Infographics

×

Growth momentum in the Asia-Pacific Distributed Denial of Services (DDoS) solutions market remained strong in 2015, registering a robust growth of 34.4% on a YoY basis. A total revenue of $266.6 million was generated by on-premise and cloud-based solutions together. As DDoS attacks continued to escalate in 2015 with new motivation, tactics, and vec...

22 Aug 2024  |  Global  |  Technology Research

Pipeline Assessment for Cardiovascular Diseases

Advanced Drug Modalities Fuel Cardiovascular Therapeutics Future Growth Potential

Infographics

×

Globally, CVD is the leading cause of death, with resurgence in higher-income countries and higher prevalence in low- and middle-income countries. While there have been many advancements made to this indication using wearables and advanced diagnostics and devices, growth in therapeutics has been veiled. Traditional pharmacotherapy faces the drawbac...

The distribution infrastructure and delivery sector is undergoing a profound transformation, driven by the explosive growth of digital content consumption, the proliferation of edge computing, and the relentless evolution of security threats in an increasingly interconnected world. The focus in this sector has shifted from simply moving data effici...

Mitochondria are vital structures in the human body, and they play an active role in several processes. They are widely recognized as the powerhouses of the cell because of their essential function in energy production. In addition, mitochondria have a significant impact on several functions of the human body; as a result, any dysfunction in mitoch...

The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...